Undifferentiated Pleomorphic Sarcoma

Observed

→ investigated in trials for

Pembrolizumabmonoclonal_antibody

6 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal_antibody

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal_antibody

4 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal_antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Futibatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lifileucelcell therapy

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Romidepsinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sintilimabmonoclonal_antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talimogene Laherparepvecgene therapy

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trabectedinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vimseltinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Undifferentiated Pleomorphic Sarcoma studied in …STUDIED_INderived10 of 53show all (up to 200)
→ studied in	NCT02923778Phase 2 · active not recruiting Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06422806Phase 3 · recruiting Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas · condition mapped CURATED_BROADER · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07823491Phase 3 · not yet recruiting Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall · condition mapped CURATED_BROADER · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07802652Phase 2 · not yet recruiting Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03307616Phase 2 · active not recruiting Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery · condition mapped CURATED_BROADER · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07817095Phase 2 · not yet recruiting SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05711615Phase 1 · recruiting Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07741877Phase 2 · not yet recruiting A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)	—	—	Undifferentiated Pleomorphic Sarcoma	1	Observed	clinicaltrials	graph →

Undifferentiated Pleomorphic Sarcoma studied in …STUDIED_INderived10 of 53show all (up to 200)

→ studied in

NCT02923778Phase 2 · active not recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT06422806Phase 3 · recruiting

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas · condition mapped CURATED_BROADER · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT07823491Phase 3 · not yet recruiting

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall · condition mapped CURATED_BROADER · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT07802652Phase 2 · not yet recruiting

Doxorubicin With or Without DT-7012 in Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT03307616Phase 2 · active not recruiting

Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery · condition mapped CURATED_BROADER · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT07817095Phase 2 · not yet recruiting

SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT05711615Phase 1 · recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma · condition mapped CURATED_BROADER · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT05827614Phase 1 · terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT06239272Phase 1/Phase 2 · recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed

→ studied in

NCT07741877Phase 2 · not yet recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 53 trials mapped (21 active)

—

Observed